Warner Chilcott
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Warner Chilcott sits in the top decile of US sponsors by registered trial count (#359 of 15,742 sponsors by registered trial count).
Warner Chilcott: 53 sponsored US clinical trials, none currently recruiting.
Warner Chilcott sponsors 53 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 47 completed. 29 of these trials are in Phase 3-4 (later-stage) and 21 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Postmenopausal Osteoporosis, with 4 trials.
Top-decile sponsor footprint
Warner Chilcott ranks in the top decile of sponsors by registered trial count (#359 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
47 of 53 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
53 total, page 2 of 2
Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido
NCT00331123
Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)
NCT00577473
Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis
NCT00073021
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 10 |
| Phase 2 | 11 |
| Phase 3 | 27 |
| Phase 4 | 2 |
How the Warner Chilcott archive is shaped
53 indexed studies, none listed as recruiting (0% open); 47 completed (89%).
Phase mix: 29 late (III/IV) vs 21 early (I/II) (balanced across stages).
Top condition: Postmenopausal Osteoporosis (4 trials), 9 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Warner Chilcott: archived-pipeline peers nationwide
Peers matched on 53 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Warner Chilcott sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 53 archived trials
- BioNTech SE · 53 trials · 36% recruiting
- Société des Produits Nestlé (SPN) · 53 trials · 2% recruiting
- W.L.Gore & Associates · 53 trials · 21% recruiting
- AdventHealth Translational Research Institute · 54 trials · 24% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Warner Chilcott page
53 registered trials is a research-attention snapshot, not an endorsement of Warner Chilcott or any single study.
- None of Warner Chilcott's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Postmenopausal Osteoporosis is the condition Warner Chilcott studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Postmenopausal Osteoporosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Warner Chilcott pipeline card: 53 registered trials from official public datasets.Report a data error.